Blood–Brain Barrier Neurovulnerability Test
BBBNeuro-Dx
The blood–brain barrier (BBB) controls molecules and cells that are transported in and out of the brain, ensuring the appropriate environment for brain function, and protecting the brain from disease. However, many circulating molecules influence BBB over time, with some protecting its structure and function, while others disrupting it.
• When the BBB is compromised, impaired molecular transport across a disrupted BBB affects brain health and provides a starting point for neurodegenerative and behavioral disorders and can amplify an existing brain tumor-promoting microenvironment.
BBBNeuro-Dx is a Laboratory Developed Test providing a comprehensive molecular profile on the BBB’s integrity and its clinical implications.
• The test determines the blood levels and interrelationships of well-known molecules associated with BBB protection and disruption.
• Based on AI-driven interpretation of tested biomarkers, BBBNeuro-Dx identifies actionable molecular phenotypes across a broad spectrum of neurological and psychiatric conditions, alerting on early risks and providing the foundation for personalized intervention strategies and targeted therapies.
Why BBBNeuro-Dx Matters
Key Benefits
Advancing brain health with early, non-invasive insights
Early Detection
Identifies blood–brain barrier disruption before clinical symptoms appear.
Non-Invasive Analysis
Replaces invasive CSF sampling with a simple blood-based test.
Broad Clinical Applications
Supports evaluation across trauma, substance exposure, neurodegeneration, and infectious disease.
Foundation for Precision Care
Enables targeted therapies and prevention strategies through molecular insights.
Offered Clinical Interpretation Services
Interpretation
The BBBNeuro-Dx test supports a variety of condition-specific clinical interpretations. These services transform raw biomarker data into meaningful, actionable insights for patients and physicians.
Identifies molecular signatures of toxic exposure impacting brain health.
Evaluates BBB disruption patterns linked to chronic alcohol consumption and cognitive decline.
Detects biomarkers of structural and functional damage to the brain following head trauma.
Get Started
Register now for the Blood–Brain Barrier Neurovulnerability Test (BBBNeuro-Dx) to gain early insights into brain protection and uncover hidden risks for neurological disease.
